LATHAM & WATKINS

Comment: A firm recommended for advice in the healthcare sector which impresses in particular with its experience in complex transactions featuring regulatory elements. The team is regularly involved in industry-specific deals, the best recent example being the advice given to Astellas in purchasing Ganymed. Latham stands out from the competition through its expertise at the interface with private equity. The practice advises many pharma and medical product manufacturers in connection with transaction advice, also on ongoing regulatory matters. Besides this, Latham is also seeing a steep rise in instructions connected to contract drafting and project consultation: the practice regularly advises on global distribution agreements, R&D contracts, clinical trials and European market entry.
Strengths: Complex transactions with regulatory elements.
Recommended: Dr. Henning Schneider.
Practice: Focus on ?M&A transactions, often cross-border. Distinct interface with ?corporate and ?private equity/venture capital. Frequent regulatory advice on pharmaceuticals and medical product law (clinical trials, distribution, market access). Contract design. Also social/reimbursement law, antitrust, compliance and employment as well as patent law. Clients: pharma research companies, medical product manufacturers, biotech companies. Financial investors. Also hospitals and care home operators. (3 partners, 12 associates)
Clients: ?? Astellas on acquisition of Ganymed; Novo A/S on investment in Evotec; Siemens on global reorganization of its medical devices division; SHL Telemedizin on integrated care contracts; HanseMerkur on development of business models in the field of health management.
  • Teilen